The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum

Hear from Javed Butler, MD, and Lee Goldberg, MD, as they discuss the importance of integrating SGLT2 inhibitors across the spectrum of heart failure. Improve your ability to initiate SGLT2 inhibitors, download slides to use as a resource, and review expert commentaries on adverse event management and medication adjustment considerations.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company